2020, Number 3
<< Back Next >>
Rev Méd Electrón 2020; 42 (3)
Chronic fatigue syndrome in the course of Hepatitis C
Arredondo BAE, Arredondo RAE, Trujillo LYL
Language: Spanish
References: 11
Page:
PDF size: 93.90 Kb.
ABSTRACT
It is believed that almost 80 million persons are infected with the Hepatitis C virus
around the world, and 60 % of them suffer the chronic fatigue syndrome. For that
reason we present the case of a patient who is a carrier of the chronic fatigue
syndrome for more than two years. Reports of international research have showed the
relation between the immune answer and the damage caused by the infection of the
hepatitis C virus in the brain tissues. The aim of this work is presenting the first case
reported in Cuba.
REFERENCES
Dirks M, Pflugrad H, Haag K, et al. Persistent Neuropsychiatric Impairment in HCV Patients Despite Clearance of the Virus? J Viral Hepat. 2017; 24(7):541- 50. Citado en Pubmed; PMID: 28117537.
Pflugrad H, Meyer GJ, Dirks M. Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunction. J Viral Hepat. 2016; 23:348–57. Citado en Pubmed; PMID: 26768955.
Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. Jama. 2015; 313(11), 1101-2. Citado en Pubmed; PMID: 25668027.
Venneti S, Lopresti BJ, Wiley CA. Molecular imaging of microglia/macrophages in the brain. Glia. 2013 ;61(1):10–23. Citado en Pubmed; PMID: 22615180.
Grover VP, Pavese N, Koh SB. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat. 2012 ;19(2):e89– e96. Citado en Pubmed; PMID:22239531.
Tully D C, Hjerrild S, Leutscher PD, et al. Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients. Liver International. 2016; 36(10), 1418-24. Citado en Pubmed; PMID: 27045383.
Rodger AJ, Jolley D, Thompson SC, et al. The Impact of Diagnosis of Hepatitis C Virus on Quality of Life. Hepatology. 1999; 30:1299–301. Citado en Pubmed; PMID: 10534353.
García-Bustos V, Esplugues-Mota JV, Martí-Rodrigo A. Human Immunodeficiency Virus–Hepatitis C virus coinfection: towards a new therapeutic scenario. Rev haban cienc méd [Internet] 2017 [citado 19/11/17];16(2): [aprox 18 p]. Disponible en: https://www.medigraphic.com/cgibin/ new/resumenI.cgi?IDREVISTA=260&IDARTICULO=75559&IDPUBLICACION=7331
Kraus MR, Schäfer A, Teuber G. Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C. Hepatology 2013;58:497– 504. Citado en Pubmed; PMID:23300053.
Maggi F, Focosi D, Lanini L, et al. Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients. Clin Microbiol Infect 2012 Feb; 18(2):184-8. Citado en Pubmed; PMID: 21672082.
Hengst J, Schlaphoff V, Deterding K, et al. DAA-induced HCV learance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis C. Journal of Hepatology Internet]. 2016[citado 1511/17]; 214:1965– 74. Disponible en: https://www.journal-ofhepatology. eu/action/showCitFormats?pii=S0168-8278%2816%2900671- 1&doi=10.1016%2FS0168-8278%2816%2900671-1